LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
Hs 578T PHA-665752
1.11
uM
LJP5
0.9550 0.0239 0.9597 0.0182
Hs 578T PHA-665752
3.33
uM
LJP5
0.9505 0.0118 0.9536 0.0101
Hs 578T PHA-665752
10
uM
LJP5
0.2493 0.1825 -0.1306 0.3349
Hs 578T PI103
0.04
uM
LJP6
0.6903 0.0334 0.6755 0.0273
Hs 578T PI103
0.12
uM
LJP6
0.4750 0.0092 0.3973 0.0433
Hs 578T PI103
0.37
uM
LJP6
0.3777 0.0333 0.2487 0.0767
Hs 578T PI103
1.11
uM
LJP6
0.3332 0.0456 0.1740 0.0915
Hs 578T PI103
3.33
uM
LJP6
0.3184 0.0495 0.1478 0.0956
Hs 578T PI103
10
uM
LJP6
0.2881 0.0572 0.0951 0.0767
Hs 578T Dovitinib
0.04
uM
LJP5
0.7952 0.0076 0.7912 0.0272
Hs 578T Dovitinib
0.12
uM
LJP5
0.5935 0.0177 0.5623 0.0200
Hs 578T Dovitinib
0.37
uM
LJP5
0.4027 0.0684 0.3003 0.0477
Hs 578T Dovitinib
1.11
uM
LJP5
0.3844 0.0722 0.2706 0.0561
Hs 578T Dovitinib
3.33
uM
LJP5
0.3914 0.0595 0.2827 0.0454
Hs 578T Dovitinib
10
uM
LJP5
0.3772 0.0931 0.2540 0.0910
Hs 578T GSK 690693
0.04
uM
LJP5
0.8491 0.0183 0.8462 0.0334
Hs 578T GSK 690693
0.12
uM
LJP5
0.8051 0.0245 0.7983 0.0434
Hs 578T GSK 690693
0.37
uM
LJP5
0.7387 0.0246 0.7263 0.0482
Hs 578T GSK 690693
1.11
uM
LJP5
0.7296 0.0378 0.7131 0.0619
Hs 578T GSK 690693
3.33
uM
LJP5
0.7358 0.0531 0.7171 0.0754
Hs 578T GSK 690693
10
uM
LJP5
0.7438 0.0484 0.7279 0.0688
Hs 578T SNS-032
0.04
uM
LJP6
0.7895 0.0246 0.7860 0.0254
Hs 578T SNS-032
0.12
uM
LJP6
0.1832 0.0435 -0.1232 0.0682
Hs 578T SNS-032
0.37
uM
LJP6
0.1725 0.0356 -0.1462 0.0545
Hs 578T SNS-032
1.11
uM
LJP6
0.1691 0.0356 -0.1548 0.0698